|
🐜
|
Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
9 auth.
A. Bayés‐Genís,
M. de Antonio,
J. Vila,
J. Peñafiel,
A. Galán,
J. Barallat,
...
E. Zamora,
A. Urrutia,
J. Lupón
|
7 |
2014 |
7
🐜
|
|
🐜
|
Combined use of high‐sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure
12 auth.
A. Bayés‐Genís,
M. Antonio,
A. Galán,
H. Sanz,
A. Urrutia,
R. Cabanes,
...
L. Cano,
B. González,
C. Díez,
T. Pascual,
R. Elosúa,
J. Lupón
|
7 |
2012 |
7
🐜
|
|
🐜
|
Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
8 auth.
A. Bayés‐Genís,
J. Barallat,
A. Galán,
M. de Antonio,
M. Domingo,
E. Zamora,
...
A. Urrutia,
J. Lupón
|
7 |
2015 |
7
🐜
|
|
🐜
|
Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)
8 auth.
J. Lupón,
M. de Antonio,
J. Vila,
J. Peñafiel,
A. Galán,
E. Zamora,
...
A. Urrutia,
A. Bayés‐Genís
|
6 |
2014 |
6
🐜
|
|
🐜
|
Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
13 auth.
J. Lupón,
H. Gaggin,
M. de Antonio,
M. Domingo,
A. Galán,
E. Zamora,
J. Vila,
J. Peñafiel,
A. Urrutia,
E. Ferrer,
...
N. Vallejo,
J. Januzzi,
A. Bayés‐Genís
|
6 |
2015 |
6
🐜
|
|
🐜
|
Soluble ST2 serum concentration and renal function in heart failure.
10 auth.
A. Bayés‐Genís,
E. Zamora,
M. de Antonio,
A. Galán,
J. Vila,
A. Urrutia,
...
C. Díez,
R. Coll,
S. Altimir,
J. Lupón
|
6 |
2013 |
6
🐜
|
|
🐜
|
The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors.
12 auth.
E. López‐Cancio,
L. Dorado,
M. Millán,
S. Reverté,
A. Suñol,
A. Massuet,
...
A. Galán,
M. T. Alzamora,
G. Pera,
Pere Torán,
A. Dávalos,
J. Arenillas
|
6 |
2012 |
6
🐜
|
|
🐜
|
Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis: The Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) Study
13 auth.
E. López‐Cancio,
A. Galán,
L. Dorado,
M. Jiménez,
María Hernández,
M. Millán,
S. Reverté,
A. Suñol,
J. Barallat,
A. Massuet,
...
M. T. Alzamora,
A. Dávalos,
J. Arenillas
|
6 |
2012 |
6
🐜
|
|
🐜
|
Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
7 auth.
J. Lupón,
M. de Antonio,
A. Galán,
J. Vila,
E. Zamora,
A. Urrutia,
...
A. Bayés‐Genís
|
6 |
2013 |
6
🐜
|
|
🐜
|
Propranolol plus isosorbide‐5‐mononitrate for portal hypertension in cirrhosis: Long‐term hemodynamic and renal effects
9 auth.
R. Morillas,
R. Planas,
E. Cabré,
A. Galán,
J. Quer,
F. Feu,
...
J. Pagan,
J. Bosch,
M. Gassull
|
6 |
1994 |
6
🐜
|
